title: Acidosis activation of the proton-sensing GPR4 receptor stimulates vascular endothelial cell inflammatory responses revealed by transcriptome analysis.
abstract: Acidic tissue microenvironment commonly exists in inflammatory diseases, tumors, ischemic organs, sickle cell disease, and many other pathological conditions due to hypoxia, glycolytic cell metabolism and deficient blood perfusion. However, the molecular mechanisms by which cells sense and respond to the acidic microenvironment are not well understood. GPR4 is a proton-sensing receptor expressed in endothelial cells and other cell types. The receptor is fully activated by acidic extracellular pH but exhibits lesser activity at the physiological pH 7.4 and minimal activity at more alkaline pH. To delineate the function and signaling pathways of GPR4 activation by acidosis in endothelial cells, we compared the global gene expression of the acidosis response in primary human umbilical vein endothelial cells (HUVEC) with varying level of GPR4. The results demonstrated that acidosis activation of GPR4 in HUVEC substantially increased the expression of a number of inflammatory genes such as chemokines, cytokines, adhesion molecules, NF-κB pathway genes, and prostaglandin-endoperoxidase synthase 2 (PTGS2 or COX-2) and stress response genes such as ATF3 and DDIT3 (CHOP). Similar GPR4-mediated acidosis induction of the inflammatory genes was also noted in other types of endothelial cells including human lung microvascular endothelial cells and pulmonary artery endothelial cells. Further analyses indicated that the NF-κB pathway was important for the acidosis/GPR4-induced inflammatory gene expression. Moreover, acidosis activation of GPR4 increased the adhesion of HUVEC to U937 monocytic cells under a flow condition. Importantly, treatment with a recently identified GPR4 antagonist significantly reduced the acidosis/GPR4-mediated endothelial cell inflammatory response. Taken together, these results show that activation of GPR4 by acidosis stimulates the expression of a wide range of inflammatory genes in endothelial cells. Such inflammatory response can be suppressed by GPR4 small molecule inhibitors and hold potential therapeutic value.
authors.affiliation: Department of Oncology, Brody School of Medicine, East Carolina University, Greenville, North Carolina, United States of America.
authors.forename: Lixue
authors.initials: L
authors.lastname: Dong
authors.forename: Zhigang
authors.initials: Z
authors.lastname: Li
authors.forename: Nancy R
authors.initials: NR
authors.lastname: Leffler
authors.forename: Adam S
authors.initials: AS
authors.lastname: Asch
authors.forename: Jen-Tsan
authors.initials: JT
authors.lastname: Chi
authors.forename: Li V
authors.initials: LV
authors.lastname: Yang
mesh_terms: D000138:Acidosis / Q000503:physiopathology*; D002478:Cells, Cultured; D020869:Gene Expression Profiling / Q000379:methods; D061307:Human Umbilical Vein Endothelial Cells / Q000378:metabolism*; D006801:Humans; D043562:Receptors, G-Protein-Coupled / Q000235:genetics / Q000378:metabolism*
chemical_list: C091670:GPR4 protein, human; D043562:Receptors, G-Protein-Coupled